← All stocks

BIO vs PEN

Bio-Rad Laboratories Inc. Class A Common Stock vs Penumbra Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
BIO
PEN
Composite score
Out of 100
59
46
Growth
35
40
Value
41
18
Quality
62
71
Momentum
97
54
Valuation
BIO
PEN
Price
376.41
317.60
Market cap
10.07B
12.51B
Trailing P/E
45.85
78.03
Forward P/E
40.98
55.25
EV / EBITDA
17.18
54.28
Dividend yield
0.0%
0.0%
Profitability
BIO
PEN
ROE
3.1%
11.4%
Net margin
8.6%
10.7%
Debt / equity
0.16
0.01
Free cash flow
374.60M
174.93M
Growth
BIO
PEN
Revenue growth (YoY)
-0.1%
14.9%
Earnings growth (YoY)
18.7%
-23.5%
Analyst target
329.00
361.83
See full analysis